Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ESMO 2016 Congress Highlights

Bristol-Myers Squibb
Posted on: 01 Sep 16

Bristol-Myers Squibb Company (NYSE: BMY) will host a teleconference on Sunday, October 9, 2016, at 7:30 p.m. CEST (1:30 p.m. EDT) to discuss data presented at the European Society of Medical Oncology (ESMO) 2016 Congress in Copenhagen, Denmark. Company executives will provide an overview of data presented at the meeting, with a focus on the company’s Immuno-Oncology portfolio, and address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at:, by dialing toll free (877) 258-2708 or international (647) 252-4456, confirmation code: 74677318. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 4:30 p.m. EDT on October 9, 2016 through 11:59 p.m. EDT on October 16. The replay can be accessed at or by dialing (855) 859-2056 or (404) 537-3406, confirmation code: 74677318.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at or follow us on LinkedInTwitter, YouTube and Facebook.

View source version on

Business Wire

Last updated on: 01/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.